The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACER THERAPEUTICS INC | Common | 00444P108 | 3,018 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| ALIMERA SCIENCES INC | Common | 016259103 | 4,481 | 6,240,000 | SH | SOLE | 6,240,000 | 0 | 0 | ||
| ALLOGENE THERAPEUTICS INC | Common | 019770106 | 27,753 | 1,128,584 | SH | SOLE | 1,128,584 | 0 | 0 | ||
| AMARIN CORP PLC | Sponsored ADR | 023111206 | 75,876 | 5,575,000 | SH | SOLE | 5,575,000 | 0 | 0 | ||
| AMICUS THERAPEUTICS INC | Common | 03152W109 | 96,998 | 10,125,000 | SH | SOLE | 10,125,000 | 0 | 0 | ||
| ARGENX SE | Sponsored ADR | 04016X101 | 82,620 | 860,000 | SH | SOLE | 860,000 | 0 | 0 | ||
| ASCENDIS PHARMA | Sponsored ADR | 04351P101 | 124,047 | 1,980,000 | SH | SOLE | 1,980,000 | 0 | 0 | ||
| ASSEMBLY BIOSCIENCES INC | Common | 045396108 | 22,620 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
| BIODELIVERY SCIENCES INTL | Common | 09060J106 | 17,483 | 4,725,000 | SH | SOLE | 4,725,000 | 0 | 0 | ||
| BIOMARIN PHARMACEUTICAL INC | Common | 09061G101 | 115,804 | 1,360,000 | SH | SOLE | 1,360,000 | 0 | 0 | ||
| ESTABLISHMENT LABS HOLDINGS INC | Common | G31249108 | 13,025 | 475,000 | SH | SOLE | 475,000 | 0 | 0 | ||
| FENNEC PHARMACEUTICALS INC | Common | 31447P100 | 7,056 | 1,105,999 | SH | SOLE | 1,105,999 | 0 | 0 | ||
| GLOBAL BLOOD THERAPEUTICS INC | Common | 37890U108 | 14,368 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
| HORIZON PHARMA PLC | Common | G4617B105 | 84,999 | 4,350,000 | SH | SOLE | 4,350,000 | 0 | 0 | ||
| IMMUNOMEDICS INC | Common | 452907108 | 252,785 | 17,714,461 | SH | SOLE | 17,714,461 | 0 | 0 | ||
| INTEC PHARMA LTD | Common | M53644106 | 18,850 | 2,500,000 | SH | SOLE | 2,500,000 | 0 | 0 | ||
| IOVANCE BIOTHERAPEUTICS INC | Common | 462260100 | 90,810 | 10,261,039 | SH | SOLE | 10,261,039 | 0 | 0 | ||
| KODIAK SCIENCES INC | Common | 50015M109 | 6,406 | 902,200 | SH | SOLE | 902,200 | 0 | 0 | ||
| LOXO ONCOLOGY INC | Common | 548862101 | 45,523 | 325,000 | SH | SOLE | 325,000 | 0 | 0 | ||
| MADRIGAL PHARMACEUTICALS INC | Common | 558868105 | 25,362 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | ||
| MIRATI THERAPEUTICS INC | Common | 60468T105 | 203,535 | 4,798,101 | SH | SOLE | 4,798,101 | 0 | 0 | ||
| NEUROCRINE BIOSCIENCES INC | Common | 64125C109 | 15 | 50,000 | SH | Call | SOLE | 50,000 | 0 | 0 | |
| OUTLOOK THERAPEUTICS INC | Common | 69012T107 | 340 | 680,000 | SH | SOLE | 680,000 | 0 | 0 | ||
| PACIRA PHARMACEUTICALS INC | Common | 695127100 | 17,208 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
| PERNIX THERAPEUTICS HOLDINGS INC | Convertible Debt | 71426VAK4 | 2,545 | 6,000,000 | PRN | SOLE | 6,000,000 | 0 | 0 | ||
| PROTEOSTASIS THERAPEUTICS INC | Common | 74373B109 | 4,212 | 1,300,000 | SH | SOLE | 1,300,000 | 0 | 0 | ||
| PTC THERAPEUTICS INC | Common | 69366J200 | 13,042 | 380,000 | SH | SOLE | 380,000 | 0 | 0 | ||
| SAREPTA THERAPEUTICS INC | Common | 803607100 | 139,141 | 1,275,000 | SH | SOLE | 1,275,000 | 0 | 0 | ||
| TELIGENT INC | Common | 87960W104 | 7,261 | 5,300,000 | SH | SOLE | 5,300,000 | 0 | 0 | ||
| TG THERAPEUTICS INC | Common | 88322Q108 | 19,475 | 4,750,000 | SH | SOLE | 4,750,000 | 0 | 0 | ||
| TRICIDA INC | Common | 89610F101 | 41,265 | 1,750,000 | SH | SOLE | 1,750,000 | 0 | 0 | ||
| SPDR SERIES TRUST - S&P BIOTECH | ETF | 78464A870 | 1,440 | 500,000 | SH | Call | SOLE | 500,000 | 0 | 0 | |
| XENON PHARMACEUTICALS INC | Common | 98420N105 | 15,144 | 2,400,000 | SH | SOLE | 2,400,000 | 0 | 0 | ||
| Y MABS THERAPEUTICS INC | Common | 984241109 | 6,305 | 310,000 | SH | SOLE | 310,000 | 0 | 0 | ||
| ZOGENIX INC | Common | 98978L204 | 72,009 | 1,975,000 | SH | SOLE | 1,975,000 | 0 | 0 | ||